Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Phase II study of oral vinorelbine in combination with carboplatin followed by consolidation therapy with oral vinorelbine as single-agent in unresectable localized or metastatic non-small cell lung carcinoma.

Reck M, Macha HN, Del Barco S, Cornes P, Vaissière N, Morand M, Riggi M, Abratt R.

Lung Cancer. 2009 Jun;64(3):319-25. doi: 10.1016/j.lungcan.2008.10.014. Epub 2008 Dec 17.

PMID:
19095327
2.

Effect of preoperative chemoradiation in addition to preoperative chemotherapy: a randomised trial in stage III non-small-cell lung cancer.

Thomas M, Rübe C, Hoffknecht P, Macha HN, Freitag L, Linder A, Willich N, Hamm M, Sybrecht GW, Ukena D, Deppermann KM, Dröge C, Riesenbeck D, Heinecke A, Sauerland C, Junker K, Berdel WE, Semik M; German Lung Cancer Cooperative Group.

Lancet Oncol. 2008 Jul;9(7):636-48. doi: 10.1016/S1470-2045(08)70156-6. Epub 2008 Jun 24.

PMID:
18583190
3.

Efficient palliation in patients with small-cell lung cancer by a combination of paclitaxel, etoposide and carboplatin: quality of life and 6-years'-follow-up results from a randomised phase III trial.

Reck M, von Pawel J, Macha HN, Kaukel E, Deppermann KM, Bonnet R, Ulm K, Hessler S, Gatzemeier U.

Lung Cancer. 2006 Jul;53(1):67-75. Epub 2006 May 19.

PMID:
16713013
4.

High-level expression of matrix-associated transforming growth factor-beta1 in benign airway stenosis.

Karagiannidis C, Velehorschi V, Obertrifter B, Macha HN, Linder A, Freitag L.

Chest. 2006 May;129(5):1298-304.

PMID:
16685022
5.

Randomized study of vinorelbine--gemcitabine versus vinorelbine--carboplatin in patients with advanced non-small cell lung cancer.

Tan EH, Szczesna A, Krzakowski M, Macha HN, Gatzemeier U, Mattson K, Wernli M, Reiterer P, Hui R, Pawel JV, Bertetto O, Pouget JC, Burillon JP, Parlier Y, Abratt R; GLOB 2 group.

Lung Cancer. 2005 Aug;49(2):233-40.

PMID:
16022917
6.

HER2/neu expression and amplification in non-small cell lung cancer prior to and after neoadjuvant therapy.

Junker K, Stachetzki U, Rademacher D, Linder A, Macha HN, Heinecke A, Müller KM, Thomas M.

Lung Cancer. 2005 Apr;48(1):59-67. Epub 2004 Dec 13.

PMID:
15777971
7.

[Survival and pattern of failure in palliative endobronchial HDR -- brachytherapy using iridium 192 in recurring bronchial carcinoma].

Macha HN, Bach P, Wahlers B, Reichle G, Kullmann HJ, Freitag L.

Pneumologie. 2005 Jan;59(1):12-7. German.

PMID:
15685483
8.
9.

[Hemoptysis].

Freitag L, Macha HN.

Internist (Berl). 2004 May;45(5):555-64. German.

PMID:
15054577
10.

Combined modality treatment for locally advanced non-small cell lung cancer: preoperative chemoradiation does not result in a poorer quality of life.

Schumacher A, Riesenbeck D, Braunheim M, Wewers D, Heinecke A, Semik M, Hoffknecht P, Macha HN, Klinke F, Schmidt EW, Willich N, Berdel WE, Thomas M; German Lung Cancer Cooperative Group.

Lung Cancer. 2004 Apr;44(1):89-97.

PMID:
15013587
11.

[Bronchial carcinoma. Epidemiology, diagnosis and therapy].

Macha HN.

Internist (Berl). 2003 Jun;44 Suppl 1:S28-34. German.

PMID:
14567086
12.

Randomized phase III trial of paclitaxel, etoposide, and carboplatin versus carboplatin, etoposide, and vincristine in patients with small-cell lung cancer.

Reck M, von Pawel J, Macha HN, Kaukel E, Deppermann KM, Bonnet R, Ulm K, Hessler S, Gatzemeier U.

J Natl Cancer Inst. 2003 Aug 6;95(15):1118-27.

PMID:
12902441
13.

Early tandem high-dose ifosfamide, carboplatin, etoposide therapy with stem cell rescue for small-cell lung cancer: brief report on the results of a phase-I/II trial.

Oelmann E, Thomas M, Serve H, Kienast J, Zühlsdorf M, Mohr M, Klinke F, Dölken G, Macha H, Schmidt EW, Berdel WE.

Oncology. 2002;63(3):248-53.

PMID:
12381904
14.

Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial.

Rosell R, Gatzemeier U, Betticher DC, Keppler U, Macha HN, Pirker R, Berthet P, Breau JL, Lianes P, Nicholson M, Ardizzoni A, Chemaissani A, Bogaerts J, Gallant G.

Ann Oncol. 2002 Oct;13(10):1539-49.

PMID:
12377641
15.

Prognostic impact of Cyfra21-1 and other serum markers in completely resected non-small cell lung cancer.

Reinmuth N, Brandt B, Semik M, Kunze WP, Achatzy R, Scheld HH, Broermann P, Berdel WE, Macha HN, Thomas M.

Lung Cancer. 2002 Jun;36(3):265-70.

PMID:
12009236
16.

ERS/ATS statement on interventional pulmonology. European Respiratory Society/American Thoracic Society.

Bolliger CT, Mathur PN, Beamis JF, Becker HD, Cavaliere S, Colt H, Diaz-Jimenez JP, Dumon JF, Edell E, Kovitz KL, Macha HN, Mehta AC, Marel M, Noppen M, Strausz J, Sutedja TG; European Respiratory Society/American Thoracic Society.

Eur Respir J. 2002 Feb;19(2):356-73. No abstract available.

17.

[Argon plasma coagulation in bronchology: a new method--alternative or complementary?].

Reichle G, Freitag L, Kullmann HJ, Prenzel R, Macha HN, Farin G.

Pneumologie. 2000 Nov;54(11):508-16. German.

PMID:
11132548
18.

Impact of preoperative bimodality induction including twice-daily radiation on tumor regression and survival in stage III non-small-cell lung cancer.

Thomas M, Rübe C, Semik M, von Eiff M, Freitag L, Macha HN, Wagner W, Klinke F, Scheld HH, Willich N, Berdel WE, Junker K.

J Clin Oncol. 1999 Apr;17(4):1185.

PMID:
10561177
19.

Trimodality therapy in stage III non-small cell lung cancer: prediction of recurrence by assessment of p185neu.

Thomas M, Rübe C, Semik M, von Eiff M, Klinke F, Macha HN, Freitag L, Scheld HH, Willich N, Berdel WE, Junker K.

Eur Respir J. 1999 Feb;13(2):424-9.

20.

[Experiences with fluorescence diagnosis and photodynamic therapy in a multimodality therapy concept of operated, recurrent bronchial carcinoma].

Freitag L, Korupp A, Itzigehl I, Dankwart F, Tekolf E, Reichle G, Kullmann HJ, Macha HN.

Pneumologie. 1996 Oct;50(10):693-9. German.

PMID:
9019749
21.

The role of brachytherapy in the treatment and control of central bronchial carcinoma.

Macha HN, Freitag L.

Monaldi Arch Chest Dis. 1996 Aug;51(4):325-8. Review.

PMID:
8909019
22.

[Lung surgery in elderly patients, a retrospective study (1985-1994)].

Achatzy R, Kelm C, Kutzner K, Macha HN.

Langenbecks Arch Chir Suppl Kongressbd. 1996;113:828-9. German.

PMID:
9101999
23.

[Value of chemotherapy in multi-modal treatment of non-small-cell bronchial carcinoma].

Thomas M, Macha HN, Rübe C, van de Loo J.

Dtsch Med Wochenschr. 1995 Nov 24;120(47):1627-30. Review. German. No abstract available.

PMID:
7493564
24.

[Pleuro-mediastinitis in pulmonary actinomycosis as a rare differential bronchial carcinoma diagnosis].

Orth M, Achatzy R, Macha HN, Müller KM, Wiebe V, Schultze-Werninghaus G.

Pneumologie. 1995 Sep;49(9):505-8. German.

PMID:
8532645
26.

Pattern of failure and survival in endobronchial laser resection. A matched pair study.

Macha HN, Becker KO, Kemmer HP.

Chest. 1994 Jun;105(6):1668-72.

PMID:
7515777
27.

Treating plombage complications. Techniques available?

Wichmann M, Macha HN, Bas R, Hemer L, Zachgo W, Mikloweit P.

Chest. 1994 May;105(5):1622. No abstract available.

PMID:
8181385
28.

The role of ultrasound assisted thoracoscopy in the diagnosis of pleural disease. Clinical experience in 687 cases.

Macha HN, Reichle G, von Zwehl D, Kemmer HP, Bas R, Morgan JA.

Eur J Cardiothorac Surg. 1993;7(1):19-22.

PMID:
8431297
29.

[Conservative therapy of malignant pleural effusion].

Macha HN, Reichle G.

Langenbecks Arch Chir Suppl Kongressbd. 1992:186-9. German.

PMID:
1283539
30.

[Bronchial carcinoma: how far should the diagnosis go?].

Macha HN.

Pneumologie. 1991 Jun;45(6):508-10. German. No abstract available.

PMID:
1924226
32.

[Thrombosis of the left jugular-subclavian vein junction as a rare late complication of oleothorax].

Halm H, Achatzy R, Macha HN, Wahlers B.

Pneumologie. 1990 Nov;44(11):1264-6. German.

PMID:
2281078
33.

[Mediastinal staging of non-small cell bronchial carcinoma. The place of computed tomography and mediastinoscopy].

Vestring T, Achatzy R, Wahlers B, Macha HN, Peters PE.

Radiologe. 1990 Apr;30(4):178-84. German.

PMID:
2160672
34.

The diagnosis, therapy and prognosis of diffuse malignant mesothelioma.

Achatzy R, Beba W, Ritschler R, Wörn H, Wahlers B, Macha HN, Morgan JA.

Eur J Cardiothorac Surg. 1989;3(5):445-7; discussion 448.

PMID:
2635926
36.

[New methods in the radiotherapy of bronchial carcinoma. Endobronchial small-field irradiation using the iridium-129 high-dose afterloading technic in combination with the neodymium-YAG laser].

Macha HN, Mai J, Stadler M, Koch K, Loddenkemper R, Krumhaar D, Schumacher W.

Dtsch Med Wochenschr. 1986 May 2;111(18):687-91. German.

PMID:
2421994
37.

[New possibilities in radiotherapy of endobronchial tumors using the afterloading method in combination with laser technics].

Schumacher W, Koch K, Frost D, Michel L, Plümecke M, Lübbert K, Mai J, Krumhaar D, Macha HN, Stadler M.

Strahlentherapie. 1985 Nov;161(11):663-8. German.

PMID:
4071566
38.

[Effect of bronchoscopy (rigid and fiberoptic) on respiratory mechanics and reactivity of the airways].

Petro W, Zimmermann W, Loddenkemper R, Macha HN, Konietzko N.

Prax Klin Pneumol. 1983 Oct;37 Suppl 1:866-70. German. No abstract available.

PMID:
6647358
39.

[Pharmacotherapy of severe asthma attacks. New aspects of conventional therapy].

Magnussen H, Macha HN.

Dtsch Med Wochenschr. 1983 Aug 26;108(34):1291-5. German. No abstract available.

PMID:
6884212
40.
41.
42.

Efficacy of reproterol assessed by the acetylcholine provocation test.

Lode H, Huettemann U, Huckauf H, Macha HN, Aurich R.

Respiration. 1979;38(5):280-8.

PMID:
538336
43.

[Isosorbide dinitrate in chronic cor pulmonale (author's transl)].

Schüren KP, Macha HN.

Dtsch Med Wochenschr. 1978 May 5;103(18):777-83. German. No abstract available.

PMID:
648348
44.
45.

[Quantitative and qualitative determination of iron in primary and secondary pulmonary haemosiderosis].

Bungert HJ, Leonhardt H, Macha HN.

Dtsch Med Wochenschr. 1972 Apr 28;97(17):692-5 passim. German. No abstract available.

PMID:
5025683
46.

[Pulmonary hemosiderosis and glomerulonephritis (critical remarks on Goodpasture's syndrome)].

Macha HK, Bungert HJ.

Dtsch Med J. 1972 Feb 10;23(2):147-54. German. No abstract available.

PMID:
5017969
47.

[The fate of hyaline membranes in the lungs of adults after artificial respiration].

Macha HN, Masshoff W.

Beitr Pathol. 1972;145(4):365-80. German. No abstract available.

PMID:
5067278
48.

[Physico-chemical studies on the ferritin and protein spectrum in a case of pulmonary hemosiderosis with glomerulonephritis. (Goodpasture's syndrome)].

Bungert HJ, Leonhardt H, Macha HN.

Klin Wochenschr. 1971 Dec 1;49(23):1257-64. German. No abstract available.

PMID:
5135944
49.

[Immunologic studies of ferritin in a case of pulmonary haemosiderosis and glomerulonephritis (Goodpasture-syndrome)].

Bungert HJ, Leonhardt H, Macha HN.

Clin Chim Acta. 1971 Nov;35(1):231-6. German. No abstract available.

PMID:
5001738
50.

[Roentgenographic findings of a hydrochlorid acid burn of the stomach and its pathological-anatomical correlation].

Treichel J, Macha HN.

Fortschr Geb Rontgenstr Nuklearmed. 1971 Jul;115(1):120-2. German. No abstract available.

PMID:
5105640

Supplemental Content

Support Center